Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018
